Signal12
Neil Edwards is a seasoned executive with extensive experience in financial leadership and strategic growth across various industries. Currently serving as the Chief Financial Officer at Signal12 since March 2024, Neil also holds the position of Managing Director at Spencer Trask & Co. since May 2019, where the focus is on funding scientific discoveries and technology innovations. Additional board affiliations include Vertec BioSolvents, Inc., and EducacionIT, which highlight a commitment to sustainable technologies and educational advancement. Previous roles include Chief Financial Officer at Vesselon, Interim CEO & Board Director at Qcor, and Chief Growth Officer at Interos Solutions, Inc., where significant growth and investment returns were achieved. Neil's educational background includes a Bachelor's degree in Mathematics and a Bachelor's degree in Mathematics and Computer Science from The Citadel, complemented by an EMBA from Duke University - The Fuqua School of Business.
This person is not in any teams
Signal12
Signal12 Inc. is a clinical-stage dry eye company that develops novel therapies to address ophthalmic diseases. Through three Phase 3 clinical studies, our proprietary topical drug, Pro-ocular™ has demonstrated efficacy in rapidly reducing signs and symptoms of dry eye disease (DED). It is the first product for DED to utilize transappendageal delivery (drug delivery via hair follicles or sweat glands in the skin) and the only product to treat DED by targeting the ophthalmic branch of the trigeminal nerve. The company has offices in Greenwich, CT and Boston, MA. Join Our Mission We are raising capital to complete Phase 3 trials and bring Pro-ocular™ to market. Invest in a future where dry eye sufferers can enjoy lasting relief and improved vision. Contact Neil Edwards, CFO, for more information at nedwards@signal12inc.com.